Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02941263 · ClinicalTrials.gov registry record
Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 20
- Enrollment target
NCT02941263 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 20 participants.
The verdict
NCT02941263 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Background: Age-related macular degeneration (AMD) affects the macula in the eye. This is the central part of the retina. It is needed for sharp, clear vision and activities like reading and driving. AMD is the leading cause of vision loss in Americans 60 years of age and older. An advanced form of AMD is called geographic atrophy or GA. It happens when light-sensitive cells in the macula die so much that central vision decreases. Objective: To learn more about geographic atrophy associated with age-related macular degeneration. Eligibility: Adults at least 55 years old with a certain kind of GA. They must be enrolled in study 08-EI-0102, 08-EI-0169, 08-EI-0043, 12-EI-0042, or 11-EI-0147 but no other studies. Design: Participants will be screened with medical history, physical exam, and an eye exam. Participants will have study visits every 3 months for 15 months, then every 6 months. They will be in the study almost 4 years. Visits will last about 8 hours. At each visit, participants may have: * Medical and eye history. Participants will answer questions about their general health and eye health. They may answer written questions about how their eye problems affect their life. * Eye exam and photographs. Eye pressure will be measured and eye movements will be checked. Pupils will be dilated with drops. The thickness of the retina will be measured and photos of the eye may be taken.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-03-08 |
| Est. Completion | 2024-05-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02941263
The ClinicalTrials.gov registry entry for NCT02941263 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02941263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02941263 about?
NCT02941263 is a clinical study titled "Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration". Background: Age-related macular degeneration (AMD) affects the macula in the eye. This is the central part of the retina. It is needed for sharp, clear vision and activities like reading and driving. AMD is the leading cause of vision loss in Americans 60 years of age and older. An advanced form of...
What is the current status of trial NCT02941263?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2017-03-08. Estimated completion is 2024-05-22.
Who is sponsoring clinical trial NCT02941263?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.